Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15403 | 643 | 30.9 | 64% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VIGABATRIN | Author keyword | 119 | 41% | 36% | 229 |
2 | VISUAL FIELD CONSTRICTION | Author keyword | 15 | 77% | 2% | 10 |
3 | GAMMA VINYL GABA | Author keyword | 9 | 34% | 3% | 21 |
4 | REFRACTORY COMPLEX PARTIAL SEIZURES | Author keyword | 6 | 100% | 1% | 4 |
5 | INTRAMYELINIC EDEMA | Author keyword | 4 | 42% | 1% | 8 |
6 | MARYLAND EYE CARE | Address | 4 | 75% | 0% | 3 |
7 | AMINOBUTYRATE AMINOTRANSFERASE | Author keyword | 2 | 44% | 1% | 4 |
8 | CAS 60643 86 9 | Author keyword | 2 | 67% | 0% | 2 |
9 | CARDIFF OPTOMETRY VIS SCI | Address | 2 | 29% | 1% | 6 |
10 | VISUAL FIELD LOSS | Author keyword | 2 | 16% | 2% | 10 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VIGABATRIN | 119 | 41% | 36% | 229 | Search VIGABATRIN | Search VIGABATRIN |
2 | VISUAL FIELD CONSTRICTION | 15 | 77% | 2% | 10 | Search VISUAL+FIELD+CONSTRICTION | Search VISUAL+FIELD+CONSTRICTION |
3 | GAMMA VINYL GABA | 9 | 34% | 3% | 21 | Search GAMMA+VINYL+GABA | Search GAMMA+VINYL+GABA |
4 | REFRACTORY COMPLEX PARTIAL SEIZURES | 6 | 100% | 1% | 4 | Search REFRACTORY+COMPLEX+PARTIAL+SEIZURES | Search REFRACTORY+COMPLEX+PARTIAL+SEIZURES |
5 | INTRAMYELINIC EDEMA | 4 | 42% | 1% | 8 | Search INTRAMYELINIC+EDEMA | Search INTRAMYELINIC+EDEMA |
6 | AMINOBUTYRATE AMINOTRANSFERASE | 2 | 44% | 1% | 4 | Search AMINOBUTYRATE+AMINOTRANSFERASE | Search AMINOBUTYRATE+AMINOTRANSFERASE |
7 | CAS 60643 86 9 | 2 | 67% | 0% | 2 | Search CAS+60643+86+9 | Search CAS+60643+86+9 |
8 | VISUAL FIELD LOSS | 2 | 16% | 2% | 10 | Search VISUAL+FIELD+LOSS | Search VISUAL+FIELD+LOSS |
9 | VISUAL FIELD DEFECTS | 2 | 13% | 2% | 12 | Search VISUAL+FIELD+DEFECTS | Search VISUAL+FIELD+DEFECTS |
10 | GVG | 1 | 27% | 1% | 4 | Search GVG | Search GVG |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GAMMA VINYL GABA | 69 | 39% | 21% | 138 |
2 | GABA TRANSAMINASE INHIBITOR | 30 | 84% | 2% | 16 |
3 | VISUAL FIELD CONSTRICTION | 24 | 53% | 5% | 32 |
4 | 4 AMINO HEX 5 ENOIC ACID | 23 | 52% | 5% | 31 |
5 | MICROVACUOLES | 21 | 85% | 2% | 11 |
6 | INDUCED INTRAMYELINIC EDEMA | 19 | 74% | 2% | 14 |
7 | TRANSAMINASE INHIBITOR | 18 | 89% | 1% | 8 |
8 | DRUG RESISTANT EPILEPSY | 15 | 29% | 7% | 44 |
9 | FIELD CONSTRICTION | 15 | 88% | 1% | 7 |
10 | ACETYLENIC GABA | 9 | 47% | 2% | 15 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Vigabatrin: 2008 Update | 2009 | 71 | 45 | 69% |
VIGABATRIN - CLINICAL PHARMACOKINETICS | 1992 | 71 | 28 | 86% |
Vigabatrin therapy for refractory complex partial seizures: review of major European trials | 2011 | 12 | 24 | 58% |
VIGABATRIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN EPILEPSY AND DISORDERS OF MOTOR CONTROL | 1991 | 251 | 111 | 64% |
Visual field defects with vigabatrin - Epidemiology and therapeutic implications | 2001 | 68 | 48 | 75% |
Vigabatrin-associated retinal damage - potential biochemical mechanisms | 2012 | 7 | 77 | 47% |
Evidence-based Review of Recommendations for Visual Function Testing in Patients Treated with Vigabatrin | 2010 | 12 | 52 | 85% |
PHARMACOLOGY OF VIGABATRIN | 1992 | 46 | 53 | 94% |
Vigabatrin | 2007 | 27 | 85 | 64% |
Vigabatrin for Infantile Spasms | 2011 | 5 | 69 | 62% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MARYLAND EYE CARE | 4 | 75% | 0.5% | 3 |
2 | CARDIFF OPTOMETRY VIS SCI | 2 | 29% | 0.9% | 6 |
3 | PHYSIOL PHARMACOLCLIN PHARMACOL SERV | 1 | 50% | 0.3% | 2 |
4 | REGULATORY DEV REGISTRAT | 1 | 100% | 0.3% | 2 |
5 | WELSH EPILEPSY UNIT | 1 | 25% | 0.5% | 3 |
6 | GLOBAL PHARMACOEPIDEMIOL | 1 | 33% | 0.3% | 2 |
7 | ALAN RICHENS UNIT | 1 | 50% | 0.2% | 1 |
8 | CLIN EXPT EPILESPY | 1 | 50% | 0.2% | 1 |
9 | CLIN NEUROPHYSIOL PEDIAT NEUROL | 1 | 50% | 0.2% | 1 |
10 | DALLAS PEDIAT NEUROL ASSOCIATES | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000274364 | LAMOTRIGINE//FELBAMATE//OXCARBAZEPINE |
2 | 0.0000273638 | 4 AMINOBUTYRATE AMINOTRANSFERASE//GAMMA AMINOBUTYRIC ACID AMINOTRANSFERASE//GABA AT |
3 | 0.0000244205 | WEST SYNDROME//INFANTILE SPASMS//HYPSARRHYTHMIA |
4 | 0.0000158099 | GABAA RECEPTOR CHLORIDE IONOPHORE COMPLEX//CEREBROSPINAL FLUID AND PLASMA LEVELS//FENGABINE |
5 | 0.0000126883 | AUDITORY DISTURBANCE//PERIPHERAL NEUROMUSCULAR FUNCTION//ACUTE FORM |
6 | 0.0000122921 | CUBE ROOT LAW//ETHYLCELLULOSE MATRIX//SQUARE ROOT TIME LAW |
7 | 0.0000122493 | BACLOFEN//CGP44532//POSTSYNAPTIC DOPAMINE RECEPTOR SUPERSENSITIVITY |
8 | 0.0000110241 | TIAGABINE//GABA UPTAKE INHIBITORS//GABA UPTAKE |
9 | 0.0000096142 | ASPARTIC SALTS//ASSOC TISSUE BANK//CHEMICAL EYE BURN |
10 | 0.0000066197 | GABAPENTIN//PREGABALIN//NEURONTIN |